Protalix Biotherapeutics (NY: PLX )
2.330 -0.100 (-4.12%) Official Closing Price Updated: 8:00 PM EDT, Jun 8, 2023 Add to My Watchlist
Headline News about Protalix Biotherapeutics
Why Lucira Health Shares Are Trading Higher By Over 228%; Here Are 20 Stocks Moving Premarket
February 27, 2023
Gainers Lucira Health, Inc. (NASDAQ: LHDX) rose 228.5% to $0.46 in pre-market trading after the FDA authorized Lucira's over-the-counter at-home test to detect both influenza and COVID-19 viruses.
Earnings Preview For Protalix BioTherapeutics
February 24, 2023
Looking Into Protalix BioTherapeutics's Return On Capital Employed
December 23, 2022
The Dow Jones closed lower by more than 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment
November 30, 2022
Via News Direct
Exposures Product Safety
Under The Hood Of Options Chain Implications — Understanding How Options Data Can Help Inform Investment Decisions
September 20, 2022
As many investors are aware, options market data can provide some critical insight into future price movements of underlying common stock. It’s often possible to tell how the broader market perceives a...
10 Most-Searched Tickers On Benzinga Pro In April: Musk Mania, Apple Drops, Several Newcomers Move Up
May 02, 2022
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. Here is a look at the...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following